Prescription drug · ANDA
Silodosin NDC 72162-2447
Silodosin 8 mg/1 · Capsule · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-2447-3 | 7216224470372162244703 | 30 CAPSULE in 1 BOTTLE (72162-2447-3)Marketed from Nov 14, 2024 | |
| 72162-2447-9 | 7216224470972162244709 | 90 CAPSULE in 1 BOTTLE (72162-2447-9)Marketed from Nov 14, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Silodosin
- Generic name (nonproprietary)
- silodosin
- Active ingredients
- Silodosin — 8 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bryant Ranch PrepackNDC labeler code 72162
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213230
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 72162-2447_5b6204b7-40c1-4071-82f4-ff5fa34c2425SPL ID 5b6204b7-40c1-4071-82f4-ff5fa34c2425SPL set ID aac3314b-af8c-400e-ba91-0cf2b95e70ddRxCUI 809477UNII CUZ39LUY82
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162244703followed by a unit qualifier and the quantityPackage 72162-2447-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Silodosin, a selective alpha‑1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see CLINICAL STUDIES (14) ] . Silodosin capsules is not indicated for the treatment of hypertension. Silodosin capsules, an alpha‑1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin capsules are not indicated for the treatment of hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 72162-2447
- What is NDC 72162-2447?
- 72162-2447 is the product NDC for Silodosin, Silodosin 8 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Silodosin.
- What is the active ingredient?
- Silodosin.
- Who is the labeler?
- Bryant Ranch Prepack, NDC labeler code 72162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Silodosin?
- 28 other product NDCs are listed under this name. See all Silodosin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Silodosin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2446 | 72162-2446-03 |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-113 | 82619-0113-01 |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-114 | 82619-0114-0182619-0114-02 |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | AvKARE | 42291-777 | 42291-0777-30 |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | AvKARE | 42291-778 | 42291-0778-90 |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-635 | 31722-0635-3031722-0635-3131722-0635-90+1 more |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-636 | 31722-0636-3031722-0636-3131722-0636-90+1 more |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-405 | 46708-0405-3046708-0405-9046708-0405-91 |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-406 | 46708-0406-3046708-0406-9046708-0406-91 |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-405 | 62332-0405-3062332-0405-9062332-0405-91 |
Other NDCs under ANDA 213230
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2446 |
| Silodosin | Silodosin 4 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-113 |
| Silodosin | Silodosin 8 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-114 |